Save information for later
Sign Up

Learn About Orchiectomy

Who are the top Orchiectomy Local Doctors?
Elite in Orchiectomy
Elite in Orchiectomy

Northwestern Medical Faculty Foundation

675 N Saint Clair St, 
Chicago, IL 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Robert Brannigan is an Urologist in Chicago, Illinois. Dr. Brannigan and is rated as an Elite provider by MediFind in Orchiectomy. His top areas of expertise are Infertility, Low Testosterone, Testicular Failure, Vasectomy, and Orchiectomy. Dr. Brannigan is currently accepting new patients.

Axel Heidenreich
Elite in Orchiectomy
Elite in Orchiectomy
Kerpener Str. 62, 
Koeln, NW, DE 

Axel Heidenreich practices in Koeln, Germany. Mr. Heidenreich and is rated as an Elite expert by MediFind in Orchiectomy. His top areas of expertise are Testicular Cancer, Prostate Cancer, Teratoma of the Mediastinum, Lymphadenectomy, and Orchiectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Martin E. Gleave
Elite in Orchiectomy
Elite in Orchiectomy
Vancouver, BC, CA 

Martin Gleave practices in Vancouver, Canada. Mr. Gleave and is rated as an Elite expert by MediFind in Orchiectomy. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Testicular Cancer, Orchiectomy, and Prostatectomy.

What are the latest Orchiectomy Clinical Trials?
Hispanic/Latino and Non-Hispanic BlAck Patients Treated with NiRaparib and Abiraterone Acetate Plus Prednisone for Metastatic HOrmone Sensitive Prostate Cancer with Deleterious Homologous RecombinatioN Repair Alterations: a Phase II, Open Label StudY

Summary: This is an open label, phase II trial in subjects with treatment naïve, metastatic hormone sensitive prostate cancer (mHSPC) with deleterious homologous recombination repair (HRR) alteration(s). These include pathologic alterations in BRCA 1/2, BRIP1, CHEK2, FANCA, PALB2, RAD51B, and/or RAD54L. A total of 64 people will be enrolled to the study.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Studying Treatments in Patients Receiving Androgen Deprivation Therapy (ADT) and Androgen Receptor Signalling Inhibitors (ARSI) for Metastatic Prostate Cancer: Evaluation of Drug and Radiation Efficacy: A 2nd Multi-arm Multi-stage Randomised Controlled Trial (STAMPEDE2).

Summary: STAMPEDE2 is a clinical trial comparing three new treatments with standard of care in people with prostate cancer that has spread to other parts of the body and is responsive to hormone therapy. People from all backgrounds and ethnicities are encouraged to take part and multiple hospitals across the UK are involved. University College London is running the trial. Each comparison within the trial h...